Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | MTOR | P42345 | 1/20 | 0.49 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.49 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.49 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.49 |
| ▸ | SLC29A1 | Q99808 | 9/20 | 0.48 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.48 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.48 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1062447 | 1.00 | LMNA (0.49) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL14084325 | 1.00 | LMNA (0.49) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL29446054 | 1.00 | LMNA (0.49) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL14534827 | 1.00 | LMNA (0.49) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL1372596 | 0.92 | LMNA (0.48) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL30356 | 0.92 | LMNA (0.48) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL11934656 | 0.91 | SLC29A1 (0.42) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL11934657 | 0.91 | SLC29A1 (0.42) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL650683 | 0.87 | CYP1A2 (0.42) | SLC29A1ADORA3CYP1A2NFKB1THPO | |
| SCHEMBL11934658 | 0.84 | SLC29A1 (0.39) | LMNASLC29A1RAB9ACYP3A4PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007030167-A1 | MODIFICATION OF DOUBLE-STRANDED RIBONUCLEIC ACID MOLECULES | NASTECH PHARMACEUTICAL COMPANY INC. (US) | 2007-03-15 | — | — | WO | claimed |
| WO-2025054459-A1 | RNAI OLIGONUCLEOTIDE CONJUGATES | DICERNA PHARMACEUTICALS, INC. (US) | 2025-03-13 | — | — | WO | disclosed |
| WO-2025029625-A1 | COMPOSITIONS AND METHODS FOR PROGRAMMED DEATH LIGAND RECEPTOR (PD-L1) EXPRESSION | DICERNA PHARMACEUTICALS, INC. (US) | 2025-02-06 | — | — | WO | disclosed |
| WO-2024208249-A1 | NUCLEOSIDE ANALOG FOR 5'-PHOSPHONATE MODIFICATION AND OLIGONUCLEOTIDE PREPARED THEREFROM | 上海舶望制药有限公司 | 2024-10-10 | — | — | WO | disclosed |
| EP-4441218-A2 | COMPOSITIONS AND METHODS FOR MODULATING APOC3 EXPRESSION | Dicerna Pharmaceuticals, Inc. (US) | 2024-10-09 | — | — | EP | disclosed |
| EP-4323518-A2 | COMPOSITIONS AND METHODS FOR INHIBITING KETOHEXOKINASE (KHK) | Boehringer Ingelheim International GmbH (DE) | 2024-02-21 | — | — | EP | disclosed |
| EP-4323519-A1 | COMPOSITIONS AND METHODS FOR MODULATING PNPLA3 EXPRESSION | Dicerna Pharmaceuticals, Inc. (US) | 2024-02-21 | — | — | EP | disclosed |
| US-20230250435-A1 | PCSK9 TARGETING OLIGONUCLEOTIDES FOR TREATING HYPERCHOLESTEROLEMIA AND RELATED CONDITIONS | DICERNA PHARMACEUTICALS, INC. | 2023-08-10 | — | — | US | disclosed |
| WO-2023141247-A2 | COMPOSITIONS AND METHODS FOR INHIBITING COMPLEMENT FACTOR B | ALEXION PHARMACEUTICALS, INC. (US) | 2023-07-27 | — | — | WO | disclosed |
| EP-4192505-A1 | SYSTEMIC DELIVERY OF OLIGONUCLEOTIDES | Dicerna Pharmaceuticals, Inc. (US) | 2023-06-14 | — | — | EP | disclosed |
| WO-2008109500-A2 | NUCLEIC ACID COMPOUNDS FOR INHIBITING PRKCA GENE EXPRESSION AND USES THEREOF | MDRNA, INC. (US) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008109547-A2 | NUCLEIC ACID COMPOUNDS FOR INHIBITING TYMP GENE EXPRESSION AND USES THEREOF | MDRNA, INC. (US) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008109353-A1 | NUCLEIC ACID COMPOUNDS FOR INHIBITING MAP2K GENE EXPRESSION AND USES THEREOF | MDRNA, INC. (US) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008109354-A1 | NUCLEIC ACID COMPOUNDS FOR INHIBITING IL18 GENE EXPRESSION AND USES THEREOF | MDRNA, INC. (US) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008109526-A1 | NUCLEIC ACID COMPOUNDS FOR INHIBITING EGR GENE EXPRESSION AND USES THEREOF | MDRNA, INC. (US) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008109520-A2 | NUCLEIC ACID COMPOUNDS FOR INHIBITING CXC GENE EXPRESSION AND USES THEREOF | MDRNA, INC. (US) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008109518-A1 | NUCLEIC ACID COMPOUNDS FOR INHIBITING WNT GENE EXPRESSION AND USES THEREOF | MDRNA, INC. (US) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008109487-A2 | NUCLEIC ACID COMPOUNDS FOR INHIBITING MME GENE EXPRESSION AND USES THEREOF | MDRNA, INC. (US) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008022046-A2 | DICER SUBSTRATE RNA PEPTIDE CONJUGATES AND METHODS FOR RNA THERAPEUTICS | NASTECH PHARMACEUTICAL COMPANY INC. (US) | 2008-02-21 | — | — | WO | disclosed |
| WO-2007030167-A1 | MODIFICATION OF DOUBLE-STRANDED RIBONUCLEIC ACID MOLECULES | NASTECH PHARMACEUTICAL COMPANY INC. (US) | 2007-03-15 | — | — | WO | disclosed |